Rights and permissions
About this article
Cite this article
Eli Lilly unveils premium pricing strategy for duloxetine. Pharmacoecon. Outcomes News 459, 14 (2004). https://doi.org/10.2165/00151234-200404590-00037
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404590-00037